Diagnostic strategies for early pancreatic cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vital Statistics Japan 2012. Cancer death (2011). Ministry of Health, Labor and Welfare. 2014. http://ganjoho.jp/data/public/statistics/backnumber/2012/files/cancer_statistics_2012.pdf . Accessed 15 Aug 2014.
Furuta K, Watanabe H, Ikeda S. Differences between solid and duct-ectatic type of pancreatic ductal carcinoma. Cancer. 1992;69:1327–33.
Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary. Pancreas. 2012;41:985–92.
Yamaguchi K, Okusaka T, Shimizu K, et al. EBM-based clinical guidelines for pancreatic cancer (2013) issued by the Japan Pancreatic Society: a synopsis. Jpn J Clin Oncol. 2014. doi: 10.1093/jjco/hyu127 .
Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561–5.
Hanada K, Amano H, Hino F, et al. Management strategies for branch duct intraductal papillary-mucinous neoplasms. Dig Endosc. 2006;18:S68–72.
Tada M, Kawase T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265–70.
Maguchi H, Tanno S, Mizuno N, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2011;40:364–70.
Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571–80.
Klein AP. Identifying people at a high risk of developing pancreatic cancer. Nat Rev. 2013;13:66–74.
Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasma in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004;2:606–21.
Hruban RH, Petersen GM, Goggins M, et al. Familiar pancreatic cancer. Ann Oncol. 1999;10(Suppl 4):69–73.
Kastrinos F, Fukushima N, Takaori K, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009;302:1790–5.
Vesen HF, Gruis NA, Frants RR, et al. Risk of developing pancreatic cancer in families with familiar atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16 Leiden). Int J Cancer. 2000;87:809–11.
Poley JW, Kluijt I, Gouma DJ, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenteol. 2009;104:2175–81.
Vasen HF, Wasser M, van Mil A, et al. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology. 2011;140:850–6.
Riker A, Libutti SK, Bartlett DL. Advances in the early detection, diagnosis, and staging of pancreatic cancer. Surg Oncol. 1997;6:157–69.
Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA19–9 in the diagnosis, prognosis and management of pancreatic adenocarcimona: an evidence based appraisal. J Gastrointest Oncol. 2012;3:105–19.
Nishiumi S, Shinohara M, Ikeda A, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010;6:518–28.
Kobayashi T, Nishiumi S, Ikeda A, et al. A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Cancer Epidemiol Biomark Prev. 2013;22:571–9.
Yu J, Li A, Hong SM, et al. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res. 2012;18:981–92.
Tricoli JV, Jacobson JW. MicroRNA: potential for cancer detection, diagnosis, and prognosis. Cancer Res. 2007;67:4553–5.
Mori Y, Ohtsuka T, Kono H, et al. A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Pancreas. 2013;42:187–92.
Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006;4:766–81.
Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796–804.
Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familiar pancreatic cancer. Gut. 2013;62:339–47.
Kamata K, Kitano M, Kudo S, et al. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy. 2014;46:22–9.
Tanaka S, Nakao M, Ioka T, et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254:965–72.
Hanada K, Iiboshi T, Hirano N, et al. Role of EUS for small pancreatic cancer less than 1 cm. Tan Sui. 2009;30:343–8 (In Japanese).
Sakamoto H, Kitano M, Takeyama Y, et al. Early diagnosis of pancreatic cancer: approach to the diagnosis of very small pancreatic cancer with emphasis of US, MDCT and EUS. Tan Sui. 2009;30:335–41 (In Japanese).
Takeshita K, Kutomi K, Haruyama T, et al. Imaging of early pancreatic cancer on multidetector row helical computed tomography. Br J Radiol. 2010;83:823–30.
Hijioka S, Ikari T, Kamei A, et al. CT and MRI findings with contrast enhancement of small pancreatic adenocarcinoma in the late phase. Hepatogastroenterology. 2007;54:389–92.
Serrano OK, Chaudhry MA, Leach SD, et al. The role of PET scanning in pancreatic cancer. Adv Surg. 2010;44:313–25.
Okano K, Kakinoki K, Akamoto S, et al. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol. 2011;17:231–5.
Seo S, Doi R, Machimoto T, et al. Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg. 2008;15:634–9.
Matsumoto I, Shirakawa S, Shinzeki M, et al. 18F-fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11:712–8.
Maguchi H. The roles of endoscopic ultrasonography in the diagnosis of pancreatic tumors. J Hepatobilbiliary Pancreat Surg. 2004;11:1–3.
Irisawa A, Sato A, Ikeda T, et al. Early diagnosis of small pancreatic cancer: role of endoscopic ultrasonography. Dig Endosc. 2009;21:S92–6.
Kimmey MB, Bronner MP, Byrd DR, et al. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc. 2002;56:S82–6.
Geenhalf W, Neoptolemos JP. Increasing survival rates of patients with pancreatic cancer by earlier identification. Nat Clin Pract Oncol. 2006;3:346–7.
Yasuda I, Iwashita T, Doi S, et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc. 2011;23(Suppl 1):22–5.
Uehara H, Ikezawa K, Kawada N, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic malignancy in relation to the size of lesions. J Gastroenterol Hepatol. 2011;26:1256–61.
Takagi T, Irisawa A, Sawaki A, et al. Effectiveness of EUS-FNA for the diagnosis of small pancreatic cancer less than 10 mm. Tan Sui. 2009;30:361–7 (In Japanese).
Yokohata K, Shirahane H, Yonemasu T, et al. Focal ductal branch on magnetic resonance cholangiopancreatography: a hint for early diagnosis of pancreatic carcinoma. Scand J Gastroenterol. 2000;11:1229–32.
Hanada K, Iiboshi T, Yamao K, et al. Diagnostic strategies for the early diagnosis of pancreatic cancer. Gastroenterol Endosc. 2012;54:3773–82 (In Japanese with English abstract).
Seki M, Ninomiya E, Takano K, et al. Pancreatogram findings for carcinoma in situ (CIS) of the pancreas seen on endoscopic retrograde cholangiopancreatography and postoperative pancreatography of resected specimens: can CIS be diagnosed preoperatively? Pancreatology. 2008;8:142–52.
Ikeda S, Maeshiro K, Ryu S, et al. Diagnosis of small pancreatic cancer by endoscopic balloon-catheter spot pancreatography. Pancreas. 2009;38:e102–13.
Brune K, Abe T, Canto M, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006;30:1067–76.
Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer. Pancreas. 2012;41:523–9.
Takaori K, Matsusue S, Fujikawa T, et al. Carcinoma in situ of the pancreas associated with localized fibrosis: a clue to early detection of neoplastic lesions arising from pancreatic ducts. Pancreas. 1998;17:102–5.
Nakaizumi A, Tatsuta M, Uehara H, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique. Cancer. 1992;70:2610–4.
Nakaizumi A, Tatsuta M, Uehara H, et al. Effectiveness of the cytologic examination of pure pancreatic juice in the diagnosis of early neoplasia of the pancreas. Cancer. 1995;76:750–7.
Mikata R, Ishihara T, Tada M, et al. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol. 2012;48:866–73.
Kimura K, Furukawa Y, Yamasaki S, et al. A study of the usefulness of pancreatic juice cytology obtained via an endoscopic nasal pancreatic drainage (ENPD) tube. Nihon Shokakibyo Gakkai Zasshi. 2011;108:928–36 (In Japanese with English abstract).
Hanada K, Iiboshi T, Hirano N, et al. A social program for diagnosis of the stage 0 pancreatic cancer in a rural doctor’s association. Pancreas. 2012;41:1156.
Hanada K, Iiboshi T. Recent advances in the early diagnosis of pancreatic cancer. Nihon Shokakibyo Gakkai Zasshi. 2013;110:2051–9 (In Japanese).
Fukasawa M, Yoda Y, Takayama I, et al. Regional cooperation aimed at the early detection of pancreatic cancer. Kan Tan Sui. 2013;66:277–84 (In Japanese).